AiCure: harnessing AI to boost adherence

AiCure is applying AI to visual, vocal and behavioral patient data to optimize trial adherence

AiCure is combining a decade’s worth of research into real-world patient behavior with an artificial intelligence platform to optimize patient adherence to treatments in clinical trials.

Lack of patient compliance to long-term treatments can lead to increases in hospitalizations, unnecessary doctor visits and lost drug sales, resulting in billions of dollars of expenses for healthcare systems and biopharmas (see “Back To School: Changing The Subject”).

According to Mario Nacinovich, AiCure’s global head, communications and marketing, non-adherence is also observed in clinical trials, which can confound safety and efficacy assessments. “People don’t take their medication or if they appear to

Read the full 981 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE